Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06587022

Delineation of Target Volume of Stereotactic Radiotherapy for Spinal Tumors

Status
Recruiting
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Peking University Third Hospital · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study was to compare efficacy and side effects of two target delineation methods for stereotactic radiotherapy of metastatic spinal tumors.

Detailed description

The purpose of this study was to compare efficacy and side effects of two target delineation methods for stereotactic radiotherapy of metastatic spinal tumors. This is a bidirectional cohort study planned to enroll approximately 500 patients with metastatic spinal tumors. Patients are divided into two groups according to the target delineation method. Group 1:The target bolume only includes local tumor. Group 2:The target bolume includes local tumor and adjacent vertebral area.

Conditions

Interventions

TypeNameDescription
RADIATIONTarget volume delineationGroup 1(small target delineation):The target bolume only includes local tumor. Group 2(small target delineation):The target bolume includes local tumor and adjacent vertebral area.

Timeline

Start date
2017-01-01
Primary completion
2026-12-30
Completion
2027-12-30
First posted
2024-09-19
Last updated
2024-09-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06587022. Inclusion in this directory is not an endorsement.

Delineation of Target Volume of Stereotactic Radiotherapy for Spinal Tumors (NCT06587022) · Clinical Trials Directory